关注
Rolf P. Kreutz, M.D.
Rolf P. Kreutz, M.D.
Professor of Clinical Medicine, Indiana University School of Medicine
在 iu.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study
PA Gurbel, KP Bliden, K Guyer, PW Cho, KA Zaman, RP Kreutz, AK Bassi, ...
Journal of the American College of Cardiology 46 (10), 1820-1826, 2005
8602005
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
LH Cavallari, CR Lee, AL Beitelshees, RM Cooper-DeHoff, JD Duarte, ...
JACC: Cardiovascular Interventions 11 (2), 181-191, 2018
2712018
Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019
TK Maatman, F Jalali, C Feizpour, II Anthony Douglas, SP McGuire, ...
Critical care medicine 48 (9), e783-e790, 2020
1942020
Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study
RP Kreutz, EJ Stanek, R Aubert, J Yao, JA Breall, Z Desta, TC Skaar, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 30 (8 …, 2010
1802010
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype‐Guided Antiplatelet Therapy
PE Empey, JM Stevenson, S Tuteja, KW Weitzel, DJ Angiolillo, ...
Clinical Pharmacology & Therapeutics 104 (4), 664-674, 2018
1172018
Pharmacogenomics of novel direct oral anticoagulants: newly identified genes and genetic variants
SH Kanuri, RP Kreutz
Journal of personalized medicine 9 (1), 7, 2019
1142019
Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the Thrombotic RIsk Progression (TRIP) study
US Tantry, KP Bliden, TA Suarez, RP Kreutz, J Dichiara, PA Gurbel
Platelets 21 (5), 360-367, 2010
982010
Quantification of intact quadriceps tendon, quadriceps tendon insertion, and suprapatellar fat pad: MR arthrography, anatomy, and cryosections in the sagittal plane
RW Staeubli H U , Bollmann C , Kreutz R , Becker W
Am J Roentgenol 173 (3), 691-8, 1999
94*1999
A comprehensive review and meta-analysis of risk factors for statin-induced myopathy
KA Nguyen, L Li, D Lu, A Yazdanparast, L Wang, RP Kreutz, EC Whipple, ...
European journal of clinical pharmacology 74, 1099-1109, 2018
842018
Platelet function measured by VerifyNow™ identifies generalized high platelet reactivity in aspirin treated patients
J Dichiara, KP Bliden, US Tantry, SK Chaganti, RP Kreutz, TB Gesheff, ...
Platelets 18 (6), 414-423, 2007
772007
A national study of the effect of individual proton pump inhibitors on cardiovascular outcomes in patients treated with clopidogrel following coronary stenting: the Clopidogrel …
EJ Stanek, RE Aubert, DA Flockhart, RP Kreutz, J Yao, JA Breall, Z Desta, ...
Paper presented al SCAI 32nd Annual Scientific Sessions. Las Vegas NV, 2009
682009
The link between heightened thrombogenicity and inflammation: pre-procedure characterization of the patient at high risk for recurrent events after stenting
PA Gurbel, KP Bliden, RP Kreutz, J Dichiara, MJ Antonino, US Tantry
Platelets 20 (2), 97-104, 2009
682009
Implementation of a pharmacogenomics consult service to support the INGENIOUS trial
MT Eadon, Z Desta, KD Levy, BS Decker, RC Pierson, VM Pratt, ...
Clinical Pharmacology & Therapeutics 100 (1), 63-66, 2016
662016
Morbid obesity and metabolic syndrome in Ossabaw miniature swine are associated with increased platelet reactivity
RP Kreutz, M Alloosh, K Mansour, Z Neeb, Y Kreutz, DA Flockhart, ...
Diabetes, metabolic syndrome and obesity: targets and therapy, 99-105, 2011
592011
Personalizing antithrombotic therapy in COVID-19: role of thromboelastography and thromboelastometry
R Chaudhary, RP Kreutz, KP Bliden, US Tantry, PA Gurbel
Thrombosis and haemostasis 120 (11), 1594-1596, 2020
552020
Race and sex differences in thrombogenicity: risk of ischemic events following coronary stenting
PA Gurbel, KP Bliden, E Cohen, IA Navickas, A Singla, MJ Antonino, ...
Blood coagulation & fibrinolysis 19 (4), 268-275, 2008
552008
Biomarker analysis by fluorokine multianalyte profiling distinguishes patients requiring intervention from patients with long-term quiescent coronary artery disease: a …
PA Gurbel, RP Kreutz, KP Bliden, J DiChiara, US Tantry
American heart journal 155 (1), 56-61, 2008
492008
Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin
RP Kreutz, P Nystrom, Y Kreutz, J Miao, R Kovacs, Z Desta, DA Flockhart, ...
Platelets 24 (2), 145-150, 2013
482013
Viral respiratory tract infections increase platelet reactivity and activation: an explanation for the higher rates of myocardial infarction and stroke during viral illness
RP Kreutz, KP Bliden, US Tantry, PA Gurbel
Journal of Thrombosis and Haemostasis 3 (9), 2108-2109, 2005
442005
CYP2C19 Genotype‐Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings
AL Beitelshees, CD Thomas, PE Empey, GA Stouffer, DJ Angiolillo, ...
Journal of the American Heart Association 11 (4), e024159, 2022
412022
系统目前无法执行此操作,请稍后再试。
文章 1–20